Wall Street brokerages predict that Dolby Laboratories, Inc. (NYSE:DLB) will post sales of $300.16 million for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Dolby Laboratories’ earnings, with estimates ranging from $297.52 million to $302.11 million. Dolby Laboratories reported sales of $267.47 million during the same quarter last year, which suggests a positive year over year growth rate of 12.2%. The company is expected to issue its next earnings report on Wednesday, April 25th.

On average, analysts expect that Dolby Laboratories will report full-year sales of $300.16 million for the current financial year, with estimates ranging from $1.17 billion to $1.18 billion. For the next financial year, analysts forecast that the firm will post sales of $1.25 billion per share, with estimates ranging from $1.23 billion to $1.27 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that that provide coverage for Dolby Laboratories.

How to Become a New Pot Stock Millionaire

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Wednesday, January 24th. The electronics maker reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.44 by $0.35. Dolby Laboratories had a return on equity of 12.02% and a net margin of 6.06%. The firm had revenue of $287.80 million for the quarter, compared to the consensus estimate of $265.75 million. During the same quarter in the prior year, the company posted $0.66 earnings per share. The firm’s revenue was up 8.1% on a year-over-year basis.

Several equities analysts have commented on DLB shares. ValuEngine upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Zacks Investment Research upgraded Dolby Laboratories from a “sell” rating to a “hold” rating in a report on Tuesday, February 27th. B. Riley downgraded Dolby Laboratories to a “hold” rating and set a $63.00 price target on the stock. in a report on Thursday, January 25th. Finally, JPMorgan Chase & Co. increased their price target on Dolby Laboratories from $63.00 to $70.00 and gave the company a “neutral” rating in a report on Thursday, January 25th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $62.00.

Shares of DLB stock traded down $0.68 during mid-day trading on Thursday, reaching $65.65. The company’s stock had a trading volume of 334,284 shares, compared to its average volume of 435,285. Dolby Laboratories has a one year low of $48.00 and a one year high of $74.29. The firm has a market capitalization of $7,017.89, a P/E ratio of 104.21, a PEG ratio of 5.58 and a beta of 0.75.

In other Dolby Laboratories news, EVP Mark Andrew Sherman sold 10,000 shares of the stock in a transaction that occurred on Friday, January 12th. The stock was sold at an average price of $65.00, for a total transaction of $650,000.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Kevin J. Yeaman sold 68,548 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $59.66, for a total value of $4,089,573.68. The disclosure for this sale can be found here. In the last quarter, insiders have sold 498,820 shares of company stock worth $31,288,698. Corporate insiders own 43.74% of the company’s stock.

Institutional investors have recently made changes to their positions in the company. Group One Trading L.P. grew its stake in shares of Dolby Laboratories by 707.3% in the fourth quarter. Group One Trading L.P. now owns 36,327 shares of the electronics maker’s stock worth $2,252,000 after acquiring an additional 31,827 shares during the last quarter. Schroder Investment Management Group acquired a new stake in shares of Dolby Laboratories in the third quarter worth $35,761,000. Highbridge Capital Management LLC acquired a new stake in shares of Dolby Laboratories in the third quarter worth $254,000. BlackRock Inc. grew its stake in shares of Dolby Laboratories by 0.8% in the fourth quarter. BlackRock Inc. now owns 3,092,122 shares of the electronics maker’s stock worth $191,712,000 after acquiring an additional 25,262 shares during the last quarter. Finally, Wells Fargo & Company MN grew its stake in shares of Dolby Laboratories by 6.0% in the third quarter. Wells Fargo & Company MN now owns 629,039 shares of the electronics maker’s stock worth $36,183,000 after acquiring an additional 35,558 shares during the last quarter. Institutional investors and hedge funds own 53.28% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Dolby Laboratories, Inc. (DLB) Expected to Announce Quarterly Sales of $300.16 Million” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.watchlistnews.com/dolby-laboratories-inc-dlb-expected-to-announce-quarterly-sales-of-300-16-million/1950841.html.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Get a free copy of the Zacks research report on Dolby Laboratories (DLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.